osimertinib

⇄

eukaryotic translation initiation factor 4E ; Homo sapiens







1 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 32398685 Osimertinib successfully combats EGFR-negative glioblastoma cells by inhibiting the MAPK pathway. 2021 Jan 2